Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 2CRSI S.A AL2SI Jun 5, 2026 49.74 -8.73   
 74Software 74SW Jun 5, 2026 37.70 -1.31   
 Ab Science AB Jun 5, 2026 0.91 -2.15   
 ABC Arbitrage ABCA Jun 5, 2026 5.40 -0.37   
 ABEO SA ABEO Jun 5, 2026 10.10 0.00   
 Abionyx Pharma ABNX Jun 5, 2026 2.75 +1.67   
 Abivax ABVX Jun 5, 2026 87.85 +4.65   
 Acanthe Developpement SA ACAN Jun 5, 2026 0.22 +1.82   
 Accor SA AC Jun 5, 2026 45.39 -0.98   
 Acheter-Louer.FR ALALO Jun 5, 2026 0.00 +12.50   
 Acteos EOS Jun 5, 2026 0.92 -1.92   
 Actia Group ALATI Jun 5, 2026 4.18 -1.42   
 Activium Group MLACT Jun 5, 2026 3.50 0.00   
 Adeunis ALARF Jun 5, 2026 0.84 0.00   
 Adocia ADOC Jun 5, 2026 4.28 +3.88   
 Adomos ALADO Jun 5, 2026 0.58 +1.56   
 Adux ALDUX Jun 5, 2026 1.63 +1.88   
 Advicenne ALDVI Jun 5, 2026 1.16 +5.26   
 Advini ALAVI Jun 5, 2026 17.00 0.00   
 Aelis Farma S.A. AELIS Jun 5, 2026 1.18 -1.67   
 Aeroports de Paris SA ADP Jun 5, 2026 107.00 0.00   
 Afyren ALAFY Jun 5, 2026 2.41 -4.55   
 Agripower France SA ALAGP Jun 5, 2026 1.10 -5.19   
 AgroGeneration ALAGR Jun 5, 2026 0.05 -2.67   
 Air France-KLM AF Jun 5, 2026 11.33 -1.22   
 Air Liquide AI Jun 5, 2026 183.40 +0.95   
 Airbus SE AIR Jun 5, 2026 178.96 +1.11   
 Akwel AKW Jun 5, 2026 6.96 -0.29   
 Akzo Nobel AKZA Jun 5, 2026 57.32 +1.24   
 Alan Allman Associates AAA Jun 5, 2026 2.00 +1.01   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.